MGI Tech & Eurofins Genomics Partner for DNBSEQ-T20×2 Sequencer

MGI Tech & Eurofins Genomics Partner for DNBSEQ-T20×2 Sequencer

By, Admin 7 March 2024

MGI Tech, Eurofins Genomics partner to elevate precision health with revolutionary DNBSEQ-T20×2 sequencer and related technologies

Overview

MGI Tech, a company committed to building core tools and technology to lead life science, announced a milestone collaboration with Eurofins Genomics Europe Genotyping A/S (Eurofins Genomics), which has placed a corporate order of the revolutionary DNBSEQ-T20×2 (T20) ultra-high throughput sequencer, along with the genomics data center ZTRON Appliance and a range of MGI’s state-of-the-art laboratory automation products and systems. This marks the first corporate order of the T20 in the Europe region, signalling a significant advancement in precision health initiatives across the continent.

Word from MGI tech

"We are thrilled to work with Eurofins Genomics to leverage T20's ultra-high throughput and remarkable cost-efficiency to empower large population genome projects across the world. With this partnership, we hope to improve accessibility of cost-effective sequencing to researchers globally,"" said Dr. Yong Hou, general manager of MGI Europe and Africa, with enthusiasm.

T20: a Genetic Sequencing Breakthrough

  • Powered by MGI’s proprietary DNBSEQä technology, T20 represents a breakthrough in genetic sequencing by significantly reducing sequencing costs to below $100 per genome when running 50,000 WGS per year, garnering global attention. 
  • Specifically designed to address the most challenging sequencing scenarios, T20 caters to a wide array of high-throughput sequencing needs in scientific and clinical research,including WGS, WGBS, stLFR, single-cell sequencing, Stereo-seq, and more. 
  • Following its launch in February 2023, T20 has gained widespread adoption among globally leading research institutions and healthcare providers.

Eurofins Genomics

  • Eurofins Genomics was founded in 1990 and is part of the Eurofins Scientific Group, a life science company with laboratories in over 50 countries and over 55,000 employees. 
  • Eurofins Genomics is one of the key emerging players in specialty esoteric and molecular clinical diagnostic testing in Europe and the United States.

MGI: Goal and Commitment

  • MGI Tech Co., Ltd. (referred to as MGI) is committed to building core tools and technology to lead life science through intelligent innovation. 
  • With a focus on R&D, production and sales of DNA sequencing instruments, reagents, and related products, MGI provides real-time, panoramic, and life course equipment and systems for precision medicine, precision agriculture, precision healthcare and other relevant industries.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!